Anaesthesia for A Patient with Eisenmenger Syndrome Undergoing LSCS

Abstract Introduction: Eisenmenger syndrome is a cyanotic congenital heart condition with pulmonary hypertension and reversed shunt, often linked to septal defects. Pregnancy-related lowered systemic resistance intensifies right-to-left shunt, posing risks for both mother and foetus. Anaesthetic management during LSCS in Eisenmenger patients should prioritize stable hemodynamics, preventing hypotension that exacerbates shunting, adequate analgesia and ensuring proper lung gas exchange to reduce shunt and acidosis. Objectives: To provide safe general anaesthesia during caesarean section to the obstetric patient with Eisenmenger syndrome. Methods: A 24-year-old primigravida at 32 weeks of gestation presented to the emergency room with breathlessness, chest pain, and bluish nail discoloration lasting for 2 days. Her oxygen saturation was 80% on room air. On admission, a 2D-ECHO revealed an ostium secondum atrial septal defect (ASD) with bidirectional shunting, pulmonary artery systolic pressure of 45mmHg and right ventricular dysfunction. The patient underwent a planned caesarean section at 34 weeks under general anaesthesia with Injection Lignocaine 2%, Injection Etomidate 0.3mg/kg, Injection Fentanyl 75mcg iv as induction agents. Intraoperatively, prophylactic intravenous dobutamine at 5-20mcg/kg/min and bolus of injection Esmolol was given as needed. Patient delivered a male child of 1.6kg with APGAR score of 6/10 and 8/10 at 1 and 5 minutes. She remained hemodynamically stable throughout the surgery and was extubated. Conclusion: General anaesthesia technique with maintenance of hemodynamics as close to normal as possible can be used for successful management of patients with Eisenmenger syndrome.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-30
DOI
https://doi.org/10.5281/zenodo.15394548
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anaesthesia for A Patient with Eisenmenger Syndrome Undergoing LSCS

Zenodo (CERN European Organization for Nuclear Research)
Pulmonary Hypertension Research and Treatments
article

Anaesthesia for A Patient with Eisenmenger Syndrome Undergoing LSCS

article en

Abstract

Abstract Introduction: Eisenmenger syndrome is a cyanotic congenital heart condition with pulmonary hypertension and reversed shunt, often linked to septal defects. Pregnancy-related lowered systemic resistance intensifies right-to-left shunt, posing risks for both mother and foetus. Anaesthetic management during LSCS in Eisenmenger patients should prioritize stable hemodynamics, preventing hypotension that exacerbates shunting, adequate analgesia and ensuring proper lung gas exchange to reduce shunt and acidosis. Objectives: To provide safe general anaesthesia during caesarean section to the obstetric patient with Eisenmenger syndrome. Methods: A 24-year-old primigravida at 32 weeks of gestation presented to the emergency room with breathlessness, chest pain, and bluish nail discoloration lasting for 2 days. Her oxygen saturation was 80% on room air. On admission, a 2D-ECHO revealed an ostium secondum atrial septal defect (ASD) with bidirectional shunting, pulmonary artery systolic pressure of 45mmHg and right ventricular dysfunction. The patient underwent a planned caesarean section at 34 weeks under general anaesthesia with Injection Lignocaine 2%, Injection Etomidate 0.3mg/kg, Injection Fentanyl 75mcg iv as induction agents. Intraoperatively, prophylactic intravenous dobutamine at 5-20mcg/kg/min and bolus of injection Esmolol was given as needed. Patient delivered a male child of 1.6kg with APGAR score of 6/10 and 8/10 at 1 and 5 minutes. She remained hemodynamically stable throughout the surgery and was extubated. Conclusion: General anaesthesia technique with maintenance of hemodynamics as close to normal as possible can be used for successful management of patients with Eisenmenger syndrome.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Good health and well-being
Openalex Percentile: Top 36%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.